American Cancer Society Extramural Grants
|
|
|
- Piers Banks
- 10 years ago
- Views:
Transcription
1 Page: 1 Clinical Research Professorship (CRP) CRP Eng, Charis, MD, PhD Cleveland Clinic Foundation Genomic Medicine Institute PTENopathies and Cancer Phenomics 07/01/ /30/2019 $400,000 CRP Stange, Kurt C., MD, PhD Department of Family Medicine Promoting Health Across Boundaries 07/01/ /30/2017 $400,000 Summary CRP Total Number of Grants: 2 Total Amount Awarded: $800,000
2 Page: 2 Graduate Scholarships in Cancer Nursing Practice (GSCNP) GSCNP Wyant (Kastenhuber), Tracy C., MSN MENTOR: Menon, Usha, PhD, RN, FAAN College of Nursing Graduate Scholarships in Cancer Nursing Practice 07/01/2014 $20,000 Summary GSCNP Total Number of Grants: 1 Total Amount Awarded: $20,000
3 Page: 3 Institutional Research Grant (IRG) IRG IRG Keri, Ruth A., PhD Department of Pharmacology Otterson, Gregory A., MD Department of Internal Medicine Institutional Research Grant 01/01/ /31/2015 Funds ended 12/31/13 Institutional Research Grant 01/01/ /31/2016 Funds ended 12/31/15 $840,000 $480,000 Summary IRG Total Number of Grants: 2 Total Amount Awarded: $1,320,000
4 Page: 4 Mentored Research Scholar Grants in Applied and Clinical Research (MRSG) MRSG Rose, Johnie, MD, PhD MENTOR: Cooper, Gregory S., MD Department of Family Medicine Modeling Colorectal Cancer Recurrence and Surveillance 06/30/2018 $707,000 MRSG Roychowdhury, Sameek, PhD, MD MENTOR: Caligiuri, Michael A., MD College of Medicine Individualized Therapies for Genomic Targets: A Personalized Oncology Pilot 11/01/ /31/2018 Transferred From University of Michigan to on 12/31/12 $729,000 Summary MRSG Total Number of Grants: 2 Total Amount Awarded: $1,436,000
5 Page: 5 Master's Training Grant in Clinical Oncology Social Work (MSW) MSW Tamburro, Nancy M., LISW-S, OSW-C University Hospitals of Cleveland Department of Social Work Master's Training Grant in Clinical Oncology SW 07/01/2014 $24,000 Summary MSW Total Number of Grants: 1 Total Amount Awarded: $24,000
6 Page: 6 Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families (PEP) PEP Zhang, Amy, PhD Department of Nursing Erectile Function and Quality of Life After Prostate Cancer Treatment Funds ended 06/30/14 $72,000 Summary PEP Total Number of Grants: 1 Total Amount Awarded: $72,000
7 Page: 7 Research Scholar Grant (RSG) RSG Benson, Don M., MD, PhD Department of Internal Medicine A Phase I/II Trial of CT-011 and Lenalidomide for Multiple Myeloma 06/30/2017 RSG Chen, Jianjun, PhD University of Cincinnati Department of Cancer Biology Cincinnati, OH The Role of mir-126 in Core-binding Factor (CBF) Acute Myeloid Leukemia 07/01/2011 Transferred From University of Chicago to University of Cincinnati on 01/11/15Funds ended 06/30/15 $765,000 RSG Fisk, Harold A., PhD Department of Molecular Genetics The Role of the Mps1 Protein Kinase in Breast Cancer 07/01/ /31/2015 Funds ended 06/30/14 $656,525 RSG Garzon, Ramiro, MD Department of Medicine Regulation of Acute Graft-Versus-Host Disease by MicroRNA-155 RSG Guo, Deliang, PhD Department of Radiation Oncology Cholesterol Homeostasis and Lipid Droplets: Role in Glioblastoma Therapy 01/01/ /31/2018 $792,000
8 Page: 8 RSG He, Xiaoming, PhD Department of Biomedical Engineering A Combined Cancer Treatment of Cryoablation and Nanoparticle Drug Delivery 07/01/2011 Transferred From University of South Carolina Research Foundation to Ohio State University on 06/30/11Funds ended 06/30/15 $722,524 RSG Jackson, Mark W., PhD Department of Pathology and Cancer Center Altered Responsiveness to Oncostatin M Signaling During Transformation 07/01/2012 RSG Kalin, Tatiana, MD, PhD Cincinnati Children's Hospital Medical Center Department of Pediatrics Cincinnati, OH Transcriptional Regulation of Cancer Progression and Metastasis by FoxM1 06/30/2017 $755,000 RSG LaFramboise, Thomas, PhD Department of Genetics and Genome Sciences Tumor Suppressor Gene Identification in Myeloid Malignancies 07/01/2012 RSG Lathia, Justin, PhD Cleveland Clinic Foundation Department of Cellular and Molecular Medicine Connexin Switching Regulates Self-renewal in Glioblastoma 07/01/ /30/2019 $792,000 RSG Liu, Huiping, MD, PhD Department of Pathology The Role and Signaling Pathway of microrna-30a in Breast Cancer Progression 07/01/ /30/2019 $786,000 RSG Sampath, Deepa, PhD Department of Internal Medicine The microrna Epigenome in CLL 01/01/2013 Transferred From Ohio State University to Ohio State University on 06/30/16 $705,000
9 Page: 9 RSG Sharifi, Nima, MD Cleveland Clinic Foundation Department of Cancer Biology Challenging Assumptions About Castration-Resistance in Prostate Cancer 01/01/ /31/2016 Transferred From University of Texas Southwestern Medical Center, Dallas to Cleveland Clinic Foundation on 01/20/14Funds ended 12/31/15 RSG Taylor, Derek, PhD Department of Pharmacology Structural and Biophysical Analysis of Human Telomeres 06/30/2017 RSG Wald, David, PhD, MD Department of Pathology A Novel Approach for AML Therapy 07/01/2012 RSG Welford, Scott, PhD Department of Radiation Oncology Critical Targets in Renal Cancer 01/01/ /31/2015 RSG Wu, Jian-Qiu, PhD Department of Molecular Genetics Roles and Regulations of Rho GEFs in Fission Yeast Cytokinesis 01/01/ /31/2016 RSG Yu, Jianhua, PhD Department of Internal Medicine CS1 Chimeric Antigen Receptor-Based Immunotherapy for Multiple Myeloma 01/01/ /31/2018 $792,000 RSG Zhang, Xiaoting, PhD University of Cincinnati Department of Cancer and Cell Biology Cincinnati, OH MED1: Molecular Mechanisms Regulating Cellular Senescence in Breast Cancer 07/01/2012 $705,000
10 Page: 10 RSG Zhang, Youwei, PhD Department of Pharmacology UbcH7 Controls 53BP1 Stability and DSB Repair 07/01/ /30/2019 $792,000 RSG Zhou, Lan, MD, PhD Department of Pathology Notch loss-of-function Due to O-Fucose Deficiency in Leukemogenesis 06/30/2017 Summary RSG Total Number of Grants: 21 Total Amount Awarded: $15,463,049
11 Page: 11 Summary Grants in Effect for East Central Division, Ohio State Total Number of Grants: Total Amount Awarded: 30 $19,135,049
12 Page: 12
American Cancer Society Extramural Grants
Page: 1 Graduate Scholarships in Cancer Nursing Practice (GSCNP) GSCNP-14-118-01 Abbott, Linda, MSN MENTOR: Hooke, Mary C., PhD, RN School of Nursing Graduate Scholarship in Cancer Nursing Practice 07/01/2014
American Cancer Society Extramural Grants
Page: 1 Cancer Control Career Development Award for Primary Care Physicians (CCCDA) CCCDA-14-013-01 Cole, ison M., MD MENTOR: Baldwin, Laura-Mae, MD, MPH Department of Family Medicine Improving Colorectal
American Cancer Society Extramural Grants
Page: 1 Institutional Research Grant (IRG) IRG-13-043-01 Bennett, Charles L., MD, PhD University of South Carolina Research Foundation Department of Pharmacy Columbia, SC Supporting Outstanding Academic
American Cancer Society Extramural Grants
Page: 1 Doctoral Training Grant in Oncology Social Work Renewal (DSWR) DSWR-14-087-03 Blinka, Marcela, MSW MENTOR: BrintzenhofeSzoc, Karlynn, MSW, DSW, PhD The Catholic University of America National Catholic
American Cancer Society Extramural Grants
Page: 1 Doctoral Degree Scholarship in Cancer Nursing (DSCN) DSCN-15-092-01 Adelstein, Katharine, MSN MENTOR: Bauer-Wu, Susan, PhD, RN, FAAN The Rector and Visitors of the University of Virginia School
American Cancer Society Extramural Grants
Page: 1 Graduate Scholarships in Cancer Nursing Practice (GSCNP) GSCNP-15-122-01 Walker, Danielle, BSN MENTOR: McMillan, Susan, PhD University of South Florida College of Nursing Graduate Scholarship in
American Cancer Society Extramural Grants
Page: 1 Clinical Research Professorship (CRP) CRP-15-100-06 Olopade, Olufunmilayo I., MBBS Genomic Approaches for Primary Prevention of Triple Negative Breast Cancer 07/01/2015 06/30/2020 $400,000 Summary
American Cancer Society Extramural Grants
Page: 1 Doctoral Degree Scholarship in Cancer Nursing (DSCN) DSCN-14-080-01 Davis, Lorie L., MSN MENTOR: Carpenter, Janet, PhD, RN, FAAN Science of Nursing Care Doctoral Degree Scholarship in Cancer Nursing
American Cancer Society Extramural Grants
Page: 1 Institutional Research Grant (IRG) IRG-14-247-29 You, Ming, MD, PhD Department of Pharmacology and Toxicology Institutional Research Grant 01/01/2015 12/31/2016 $240,000 Summary IRG Total Number
Future Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
Future Directions in Cancer Research What does is mean for medical physicists and AAPM?
Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman
TECHNICAL INSIGHTS TECHNOLOGY ALERT
TECHNICAL INSIGHTS TECHNOLOGY ALERT UNLOCKING BREAST CANCER TUMORS' DRUG RESISTANCE A troubling phenomenon in breast cancer treatment is that some patients tumors become resistant to treatments over time.
LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials
LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational
Fulfilling the Promise
Fulfilling the Promise Advancing the Fight Against Cancer: America s Medical Schools and Teaching Hospitals For more than a century, the nation s medical schools and teaching hospitals have worked to understand,
Meet Your Sparrow Cancer Center Team
Meet Your Sparrow Cancer Center Team Our integrated, multidisciplinary approach means every Patient is evaluated and cared for by a team managing all aspects of care from tests and treatments, to infusions,
M110.726 The Nucleus M110.727 The Cytoskeleton M340.703 Cell Structure and Dynamics
of Biochemistry and Molecular Biology 1. Master the knowledge base of current biochemistry, molecular biology, and cellular physiology Describe current knowledge in metabolic transformations conducted
A Career in Pediatric Hematology-Oncology? Think About It...
A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T
Best of San Antonio Breast Cancer Symposium
Best of San Antonio Breast Cancer Symposium 11:45 am - 5:00 pm 5800 Rockside Woods Blvd. About the Course The San Antonio Breast Cancer Symposium is an international meeting of laboratory and clinical
Cancer Research Experience Program. Opportunities for Howard University Students. 2016 Program Year
R O S W E L L PA R K C A N C E R I N S T I T U T E S Cancer Research Experience Program Opportunities for Howard University Students 2016 Program Year THE ROSWELL PARK/HOWARD UNIVERSITY CANCER SCHOLARS
Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
SMALL BUSINESS INNOVATION RESEARCH (SBIR) SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) GRANT APPLICATIONS
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES PHS 2015-2 OMNIBUS SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH, CENTERS FOR DISEASE CONTROL AND PREVENTION, FOOD AND DRUG ADMINISTRATION, AND ADMINISTRATION
American Cancer Society Extramural Grants
Page: 1 Doctoral Degree Scholarship in Cancer Nursing (DSCN) Grant No. Investigator/Mentor/Institution Title Grant Term Grant Awarded DSCN-15-077-01 Rising, Margaret, JD, MAgr, BSN RN, BA MENTOR: Hassauneh,
TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...
CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and
Key Staff Members EXECUTIVE TEAM Nancy Price Mendenhall, MD Medical Director Stuart Klein, MHA Executive Director Zuofeng Li, DSc Physics Director
Key Staff Members EXECUTIVE TEAM Nancy Price Mendenhall, MD Medical Director A University of Florida College of Medicine faculty member since 1985, Dr. Mendenhall served as the chair of the Department
Update in Hematology Oncology Targeted Therapies. Mark Holguin
Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning
Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs
Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer
Elective Options for MS in Clinical and Translational Sciences Program
Elective Options for MS in Clinical and Translational Sciences Program NOTE: ALL ELECTIVES MUST BE GRADUATE LEVEL COURSES AND APPROVED BY A MS CTS PROGRAM DIRECTOR IN ORDER TO RECEIVE CREDIT TOWARDS MCTS
Genomic Analysis of Mature B-cell Malignancies
Genomic Analysis of Mature B-cell Malignancies Update and Lessons Learned Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center Human Oncology and Pathogenesis Program and Leukemia Service Disclaimer:
Advances in Lung Cancer: A Multidisciplinary Approach
Advances in Lung Cancer: A Multidisciplinary Approach Saturday, April 25, 2015 127 Public Square Cleveland, Ohio Learning Objectives About the Course This one-day course will provide a topical, clinically
Robert Bristow MD PhD FRCPC
Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research
National Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s National Cancer Institute
The University of Vermont: Degrees Awarded by Degree Program, 2007-8
Degree Programs: Bachelor's Degrees Degree College or School # 2007-08 Degrees AIS: Asian Studies BA College of Arts and Sciences 10 AIS: European Studies BA College of Arts and Sciences 3 AIS: Latin America
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Medicine Initiative: Building a Large U.S. Research Cohort
THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
Overview of Phase 1 Oncology Trials of Biologic Therapeutics
Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of
Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care
Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care Saturday, April 27, 2013 Cleveland Marriott Downtown at Key Center 127 Public Square Cleveland, Ohio Learning
Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?
Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY
MEDICAL BREAKTHROUGHS RESEARCH SUMMARY TOPIC: Training the Body to Fight Melanoma REPORT: 3823 BACKGROUND: Melanoma is the most dangerous form of skin cancer that can be hard to treat and fatal if not
What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals
What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application
Survivorship Care Plans Guides for Living After Cancer Treatment
Survivorship Care Plans Guides for Living After Cancer Treatment Institute of Medicine Report 2005 Recommendations for meeting needs of cancer survivors Implement survivorship care plan Build bridges
Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine
Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine Graduate Certificate in Metabolic & Nutritional Medicine Graduate Certificate Metabolic & Nutritional Medicine Purpose
Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center
Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.
BONE MARROW FAILURE DISEASE SYMPOSIUM SATURDAY SEPTEMBER 27, 2014 AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT
SATURDAY SEPTEMBER 27, 2014 THE HOTEL HERSHEY 100 Hotel Road, Hershey, PA 17033 BONE MARROW FAILURE DISEASE SYMPOSIUM AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT A CONTINUING EDUCATION SERVICE OF
HARVARD MEDICAL SCHOOL
HARVARD MEDICAL SCHOOL CANCER BIOLOGY & THERAPEUTICS PROGRAM CBT A joint initiative of the Harvard Medical School Office of Global Education and the Qatar Biomedical Research Institute (QBRI) 2015-2016
How To Help The Oncology Nursing Community
Southwest Oncology Group Nursing Committee Orientation Southwest Oncology Group Organizational Structure What is the Role of Disease & Research Committees? Define research programs and scientific priorities
Us TOO University Presents: Understanding Diagnostic Testing
Us TOO University Presents: Understanding Diagnostic Testing for Prostate Cancer Patients Today s speaker is Manish Bhandari, MD Program moderator is Pam Barrett, Us TOO International Made possible by
2013 UCM Nursing Research and Evidence-Based Practice Symposium
2013 UCM Nursing Research and Evidence-Based Practice Symposium April 12, 2013 8:00 am 4:00 pm Gwen and Jules Knapp Center for Biomedical Discovery 900 E. 57th St., Chicago, Illinois This event was made
SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.
SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR. TRACEY O CONNOR RESEARCH QUESTON Patients with previously diagnosed hematologic
Houston Cancer Institute
Houston Cancer Institute A personal path to healing Memorial-West Houston Katy Northwest Houston Southeast Houston Sugar Land Convenience for Patients State of the Art Therapies and Diagnosis Real Support
Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.
Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)
Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006
Special report Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006 Gene And Protein The gene that causes the mutation is CCND1 and the protein NP_444284 The mutation deals with the cell
Achievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for
Achievements Report August 2015 CURING CANCER Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for cancer? Since cancer is complex and comes in many forms, its
Foundations of Oncology Nursing Practice
Foundations of Oncology Nursing Practice Course Syllabus Course Lead:, RN, MN, BScN, CON(C) Associate Faculty:, RN, CON(C) Last updated January 27, 2011 Course Description: This online course will introduce
Research Associate BLOOD AND MARROW TRANSPLANT FACULTY POSITIONS HEMATOLOGY/ONCOLOGY FACULTY POSITIONS IN PRECISION CANCER MEDICINE
HEMATOLOGY/ONCOLOGY FACULTY POSITIONS IN PRECISION CANCER MEDICINE The Division of Hematology/Oncology, Department of Internal Medicine, and the University of Michigan Comprehensive Cancer Center (UMCCC)
Position Statement on Accreditation of Faculty Teaching Human Anatomy and Physiology Courses
Approved by Human Anatomy & Physiology Society Board of Directors, May 25, 2013 Position Statement on Accreditation of Faculty Teaching Human Anatomy and Physiology Courses In 2005 the Human Anatomy and
A leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
Master of Philosophy (MPhil) and Doctor of Philosophy (PhD) Programs in Life Science
CURRICULUM FOR RESEARCH POSTGRADUATE PROGRAMS Master of Philosophy (MPhil) and Doctor of Philosophy (PhD) Programs in Life Science Curriculum for Master of Philosophy (MPhil) Program in Life Science The
Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives
Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives [email protected] 2015-05-21 Functional Bioinformatics, Örebro University Vad är bioinformatik och varför
Servier Exercises Exclusive Worldwide Licensing Option with Cellectis for UCART19, an Allogeneic CAR-T Cell Therapy for Hematological Malignancies
PRESS RELEASE Servier Exercises Exclusive Worldwide Licensing Option with Cellectis for UCART19, an Allogeneic CAR-T Cell Therapy for Hematological Malignancies Servier Also Enters Into Exclusive Global
Groundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
Health Literacy and Palliative Care Nursing Perspective
Health Literacy and Palliative Care Nursing Perspective Ginger Marshall, MSN, ACNP-BC, ACHPN, FPCN President Elect, Hospice Palliative Nurses Association National Director of Palliative Care for Compassus
Masters of Science in Clinical Research (MSCR) Curriculum. Goal/Objective of the MSCR
Masters of Science in Clinical (MSCR) Curriculum Goal/Objective of the MSCR The MSCR program is an interdisciplinary research degree program housed within the Department of Epidemiology in the School of
68 th Meeting of the National Cancer Institute (NCI) NCI Council of Research Advocates (NCRA) National Institutes of Health (NIH)
68 th Meeting of the National Cancer Institute (NCI) NCI Council of Research Advocates (NCRA) National Institutes of Health (NIH) Updates on NCI Programs Building 31, C Wing, Conference Room 6 NIH Campus
Beyond the PSA: Genomic Testing in Localized Prostate Cancer
Beyond the PSA: Genomic Testing in Localized Prostate Cancer Kelvin A. Moses, MD, PhD Vanderbilt University Medical Center Wednesday, December 2, 2015 5:00 p.m. ET/2:00 p.m. PT About ZERO ZERO s mission
There must be an appropriate administrative structure for each residency program.
Specific Standards of Accreditation for Residency Programs in Radiation Oncology 2015 VERSION 3.0 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
PART 3.3: MicroRNA and Cancer
BIBM 2010 Tutorial: Epigenomics and Cancer PART 3.3: MicroRNA and Cancer Dec 18, 2010 Sun Kim at Indiana University Outline of Part 3.3 Background on microrna Role of microrna in cancer MicroRNA pathway
Medical Marijuana Use in Patients with History of SCCHN Treated with Radiotherapy
HEALTH SERVICES RESEARCH Assessment the Impact of Real-time Tumor Tracking & Reduced Planning Target Volume Margins on Quality-of-Life in Prostate Cancer Patients Treatment with Intensity Modulated Radiotherapy
American Cancer Society Extramural Grants
Page: 1 Graduate Scholarships in Cancer (GSCNP) Grant No. Investigator/Mentor/Institution Title Grant Term Grant Awarded GSCNP-15-119-01 Banks, Philwyna, BSN MENTOR: Mayer, Deborah K., PhD GSCNP-14-119-01
Nursing Oncology Training Course
King Hussein Cancer Center Nursing Oncology Training Course Oncology Nursing Program Knowledge is the mind, Attitude is the heart and Practice is the hand KAP is the human Fax +962 5300 460 ext 2343 Page
Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes
Department/Academic Unit: Pathology and Molecular Medicine Degree Program: PhD Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning
MD-PhD: Is it Right for Me? Communications Committee of the MD-PhD Section of the Group of Research, Education, and Training (GREAT) AAMC
2014 MD-PhD: Is it Right for Me? Communications Committee of the MD-PhD Section of the Group of Research, Education, and Training (GREAT) AAMC Biomedical Scientists: Multiple Pathways MD graduates pursue
Personalized Treatment for Malignant Mesothelioma
Personalized Treatment for Malignant Mesothelioma RN Taub (Onc) J Chabot (Surg) A Borczuk (Path) J Sonnet (Surg) M Kluger (Surg) R Fawwaz (Nuc. Med) E Hare (Onc) Columbia University Mesothelioma Center
Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
FACULTY POSITIONS Department of Pharmacology and Physiology Drexel University College of Medicine
CENTER FOR MEMORY AND LEARNING Department of Molecular & Cellular Biology Department of Pharmacology Tenure Track Faculty Position The Center for Memory and Learning, the Department of Molecular and Cellular
The TV Series. www.healthybodyhealthymind.com INFORMATION TELEVISION NETWORK
The TV Series www.healthybodyhealthymind.com Produced By: INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com 2005 Information Television Network.
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in
Cytotoxic and Biotherapies Credentialing Programme Module 2
Cytotoxic and Biotherapies Credentialing Programme Module 2 1. The Cell Cycle 2. Cancer Therapies 3. Adjunctive Therapies On completion of this module the RN will State the difference between a normal
FACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
Wadsworth Center. New York State Department of Health. The New Faces BMS
New York State Department of Health The New Faces of BMS The New Faces of BMS Jason Wong Adriana DePesters Jason is enrolled in the PhD course for the Fall session in the Department of Biomedical Science.
The Cancer Patient Journey. Dr. Jaco Fourie
The Cancer Patient Journey Dr. Jaco Fourie The Cancer Patient Journey Prevention and health promotion Screening Diagnosis and staging Treatment Surveillance and survivorship End of life care The Cancer
Prostate Cancer 2014
Prostate Cancer 2014 Eric A. Klein, M.D. Chairman Glickman Urological and Kidney Institute Professor of Surgery Cleveland Clinic Lerner College of Medicine Incidence rates, US Men Mortality Rates, US Men
